| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.41 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |